Works matching IS 10837159 AND DT 2018 AND VI 23 AND IP 4
Results: 20
Benefit‐Risk Summary of Regorafenib for the Treatment of Patients with Advanced Hepatocellular Carcinoma That Has Progressed on Sorafenib.
- Published in:
- Oncologist, 2018, v. 23, n. 4, p. 496, doi. 10.1634/theoncologist.2017-0422
- By:
- Publication type:
- Article
Early Steps in the Value of Cancer Care—Many Paths Remain Unexplored.
- Published in:
- Oncologist, 2018, v. 23, n. 4, p. 391, doi. 10.1634/theoncologist.2017-0611
- By:
- Publication type:
- Article
Phase I Trial of a Tablet Formulation of Pilaralisib, a Pan‐Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors.
- Published in:
- Oncologist, 2018, v. 23, n. 4, p. 401, doi. 10.1634/theoncologist.2017-0691
- By:
- Publication type:
- Article
Chemoprevention in Patients with Peutz‐Jeghers Syndrome: Lessons Learned.
- Published in:
- Oncologist, 2018, v. 23, n. 4, p. 399, doi. 10.1634/theoncologist.2017-0682
- By:
- Publication type:
- Article
Two Doctors, One Patient, and a Common Goal.
- Published in:
- Oncologist, 2018, v. 23, n. 4, p. 507, doi. 10.1634/theoncologist.2017-0554
- By:
- Publication type:
- Article
Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010–2014.
- Published in:
- Oncologist, 2018, v. 23, n. 4, p. 481, doi. 10.1634/theoncologist.2017-0398
- By:
- Publication type:
- Article
The Perils of Single‐Site Genetic Testing for Hereditary Cancer Syndromes in the Era of Next‐Generation Sequencing.
- Published in:
- Oncologist, 2018, v. 23, n. 4, p. 393, doi. 10.1634/theoncologist.2017-0372
- By:
- Publication type:
- Article
Fertility‐Sparing Treatment of Endometrial Cancer with Initial Infiltration of Myometrium by Resectoscopic Surgery: A Pilot Study.
- Published in:
- Oncologist, 2018, v. 23, n. 4, p. 478, doi. 10.1634/theoncologist.2017-0285
- By:
- Publication type:
- Article
A Phase I Dose‐Escalation Study of Clofarabine in Patients with Relapsed or Refractory Low‐Grade or Intermediate‐Grade B‐Cell or T‐Cell Lymphoma.
- Published in:
- Oncologist, 2018, v. 23, n. 4, p. 397, doi. 10.1634/theoncologist.2017-0658
- By:
- Publication type:
- Article
Safety Profile of Biosimilar Filgrastim (Zarzio/Zarxio): A Combined Analysis of Phase III Studies.
- Published in:
- Oncologist, 2018, v. 23, n. 4, p. 403, doi. 10.1634/theoncologist.2017-0348
- By:
- Publication type:
- Article
Trastuzumab Plus Pertuzumab Resistance Does Not Preclude Response to Lapatinib Plus Trastuzumab in HER2‐Amplified Colorectal Cancer.
- Published in:
- Oncologist, 2018, v. 23, n. 4, p. 474, doi. 10.1634/theoncologist.2017-0436
- By:
- Publication type:
- Article
Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real‐World Data from the Spanish Tumor Registry (R‐GETNE).
- Published in:
- Oncologist, 2018, v. 23, n. 4, p. 422, doi. 10.1634/theoncologist.2017-0364
- By:
- Publication type:
- Article
Bendamustine plus Rituximab Versus R‐CHOP as First‐Line Treatment for Patients with Follicular Lymphoma Grade 3A: Evidence from a Multicenter, Retrospective Study.
- Published in:
- Oncologist, 2018, v. 23, n. 4, p. 454, doi. 10.1634/theoncologist.2017-0037
- By:
- Publication type:
- Article
Patient‐Reported Comorbidity and Survival in Older Adults with Cancer.
- Published in:
- Oncologist, 2018, v. 23, n. 4, p. 433, doi. 10.1634/theoncologist.2017-0404
- By:
- Publication type:
- Article
Decision‐Making Capacity for Chemotherapy and Associated Factors in Newly Diagnosed Patients with Lung Cancer.
- Published in:
- Oncologist, 2018, v. 23, n. 4, p. 489, doi. 10.1634/theoncologist.2017-0187
- By:
- Publication type:
- Article
Barriers and Explanatory Mechanisms of Delays in the Patient and Diagnosis Intervals of Care for Breast Cancer in Mexico.
- Published in:
- Oncologist, 2018, v. 23, n. 4, p. 440, doi. 10.1634/theoncologist.2017-0431
- By:
- Publication type:
- Article
Pre‐ and Postoperative Chemotherapy in Localized Extremity Soft Tissue Sarcoma: A European Organization for Research and Treatment of Cancer Expert Survey.
- Published in:
- Oncologist, 2018, v. 23, n. 4, p. 461, doi. 10.1634/theoncologist.2017-0391
- By:
- Publication type:
- Article
Molecular Biomarkers of Primary and Acquired Resistance to T‐Cell‐Mediated Immunotherapy in Cancer: Landscape, Clinical Implications, and Future Directions.
- Published in:
- Oncologist, 2018, v. 23, n. 4, p. 410, doi. 10.1634/theoncologist.2017-0354
- By:
- Publication type:
- Article
Therapeutic Anticoagulation in Patients with Primary Brain Tumors or Secondary Brain Metastasis.
- Published in:
- Oncologist, 2018, v. 23, n. 4, p. 468, doi. 10.1634/theoncologist.2017-0274
- By:
- Publication type:
- Article
Perception of Curability Among Advanced Cancer Patients: An International Collaborative Study.
- Published in:
- Oncologist, 2018, v. 23, n. 4, p. 501, doi. 10.1634/theoncologist.2017-0264
- By:
- Publication type:
- Article